Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring

Published:2018-10-30 Issue:4 Volume:16 Page:546-553
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Wei Shu-Chen,Tung Chien-Chih,Weng Meng-Tzu,Wong Jau-Min

Funder

Liver Disease Treatment and Prevention Research Foundation

Publisher

Korean Association for the Study of Intestinal Diseases

Subject

Gastroenterology

Link

http://irjournal.org/upload/pdf/ir-2018-00052.pdf

Reference22 articles.

1. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

2. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

3. Established and emerging biological activity markers of inflammatory bowel disease

4. Laboratory markers in IBD: useful, magic, or unnecessary toys?

5. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance evaluation of a smartphone-based home test for fecal calprotection;Clinical Chemistry and Laboratory Medicine (CCLM);2024-07-12

2. Factors associated with cam deformity in Japanese local residents;Scientific Reports;2024-01-18

3. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease;Scientific Reports;2024-01-18

4. Validation of Rapid Fecal Calprotectin Assay “fCAL turbo” for Inflammatory Bowel Disease – Retrospective Comparative Study with Endoscopic Activity;2023-04-25

5. iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis;Journal of Clinical Medicine;2023-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3